References
- Rachlin S, Bramm E, Ahnfelt-Rønne I, Arrigoni-Martelli E. Basic anti-inflammatory compounds. N,N,N″-trisubstituted guanidines. J Med Chem 1980; 23: 13–20
- Petersen H J, Nielsen C K, Arrigoni-Martelli E. Synthesis and hypotensive activity of N-alkyl-N″-cyano-N'-pyridylguanidines. J Med Chem 1978; 21: 773–81
- Bramm E, Binderup L, Arrigoni-Martelli E. An unusual profile of activity of a new basic antiinflammatory drug, timegadine. Agents Actions 1981; 11: 402–9
- Ahnfelt-Rønne I, Arrigoni-Martelli E. Multiple effects of a new anti-inflammatory agent, timegadine, on arachidonic acid release and metabolism in neutrophils and platelets. Biochem Pharmacol 1982; 31: 2619–24
- Berry H, Bloom B, Fernandes L, Morris M. Comparison of timegadine and naproxen in rheumatoid arthritis. A placebo controlled trial. Clin Rheumatol 1983; 2: 357–61
- O'Sullivan M, Molloy M G. Comparison timegadine versus naproxen in rheumatoid arthritis. Clin Rheumatol 1985; 4: 362–3, (letter)
- Mbuyi-Muamba J M, Dequeker J. A comparative trial of timegadine and D-penicillamine in rheumatoid arthritis. Clin Rheumatol 1983; 2: 369–74
- Caruso I, Fumagalli M, Montrone F, Greco M, Boccassini L. Timegadine: long term open study in rheumatoid arthritis. Clin Rheumatol 1983; 2: 363–7
- Ritchie D M, Boyle J A, McInnes J M, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 27: 393–406
- Selroos O. Thrombocytosis in rheumatoid arthritis. Scand J Rheumatol 1972; 1: 136–40
- Hutchinson R M, Davis P, Jayson M IV. Thrombocytosis in rheumatoid arthritis. Ann Rheum Dis 1976; 35: 138–42